OptimizeRx Corporation – NASDAQ:OPRX

OptimizeRx stock price today

$15.7
+10.61
+208.45%
Financial Health
0
1
2
3
4
5
6
7
8
9

OptimizeRx stock price monthly change

-50.05%
month

OptimizeRx stock price quarterly change

-50.05%
quarter

OptimizeRx stock price yearly change

-63.90%
year

OptimizeRx key metrics

Market Cap
77.64M
Enterprise value
239.36M
P/E
-22.61
EV/Sales
3.83
EV/EBITDA
-27.94
Price/Sales
4.12
Price/Book
2.04
PEG ratio
N/A
EPS
-1.02
Revenue
78.20M
EBITDA
-18.67M
Income
-18.06M
Revenue Q/Q
51.42%
Revenue Y/Y
26.71%
Profit margin
-18.32%
Oper. margin
-19.68%
Gross margin
62.4%
EBIT margin
-19.68%
EBITDA margin
-23.87%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

OptimizeRx stock price history

OptimizeRx stock forecast

OptimizeRx financial statements

OptimizeRx Corporation (NASDAQ:OPRX): Profit margin
Jun 2023 13.81M -4.16M -30.12%
Sep 2023 16.33M -2.86M -17.54%
Dec 2023 28.36M -4.14M -14.6%
Mar 2024 19.69M -6.89M -35.04%
OptimizeRx Corporation (NASDAQ:OPRX): Analyst Estimates
Mar 2024 19.69M -6.89M -35.04%
Sep 2025 29.34M 3.48M 11.89%
Oct 2025 28.71M 2.56M 8.92%
Dec 2025 40.28M 8.12M 20.17%
  • Analysts Price target

  • Financials & Ratios estimates

OptimizeRx Corporation (NASDAQ:OPRX): Debt to assets
Jun 2023 121324874 5.50M 4.54%
Sep 2023 123929152 7.82M 6.31%
Dec 2023 183373898 56.82M 30.99%
Mar 2024 176367000 53.82M 30.52%
OptimizeRx Corporation (NASDAQ:OPRX): Cash Flow
Jun 2023 -2.36M 3.22M -7.49M
Sep 2023 1.47M -1.00M -349.42K
Dec 2023 -6.25M -26.00M 36.18M
Mar 2024 2.11M -153K -640K

OptimizeRx alternative data

OptimizeRx Corporation (NASDAQ:OPRX): Employee count
Aug 2023 109
Sep 2023 109
Oct 2023 109
Nov 2023 109
Dec 2023 109
Jan 2024 109
Feb 2024 109
Mar 2024 109
Apr 2024 109
May 2024 135
Jun 2024 135
Jul 2024 135

OptimizeRx other data

34.66% -41.42%
of OPRX is owned by hedge funds
6.16M -7.51M
shares is hold by hedge funds

OptimizeRx Corporation (NASDAQ:OPRX): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 4000
Dec 2024 20000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FEBBO WILLIAM J director, officer.. Common Stock 20,000 $5.01 $100,220
Option
ODENCE-FORD MARION officer: General Counsel and CCO
Common Stock 1,785 N/A N/A
Option
ODENCE-FORD MARION officer: General Counsel and CCO
Restricted Stock Units 1,785 N/A N/A
Option
STELMAKH EDWARD officer: CFO/COO
Common Stock 8,222 N/A N/A
Option
STELMAKH EDWARD officer: CFO/COO
Restricted Stock Units 8,222 N/A N/A
Option
STELMAKH EDWARD officer: CFO/COO
Common Stock 16,622 N/A N/A
Option
STELMAKH EDWARD officer: CFO/COO
Restricted Stock Units 16,622 N/A N/A
Option
ODENCE-FORD MARION officer: General Counsel and CCO
Common Stock 6,649 N/A N/A
Option
ODENCE-FORD MARION officer: General Counsel and CCO
Restricted Stock Units 6,649 N/A N/A
Option
SILVESTRO STEPHEN L officer: Chief Co.. Common Stock 6,649 N/A N/A
Monday, 23 December 2024
globenewswire.com
Thursday, 19 December 2024
https://thefly.com
Monday, 18 November 2024
globenewswire.com
Wednesday, 13 November 2024
seekingalpha.com
zacks.com
Thursday, 7 November 2024
zacks.com
Thursday, 31 October 2024
globenewswire.com
Thursday, 3 October 2024
zacks.com
Tuesday, 10 September 2024
globenewswire.com
Monday, 9 September 2024
globenewswire.com
Wednesday, 4 September 2024
zacks.com
Thursday, 8 August 2024
zacks.com
Thursday, 1 August 2024
zacks.com
Thursday, 25 July 2024
globenewswire.com
Monday, 15 July 2024
globenewswire.com
Thursday, 20 June 2024
globenewswire.com
Tuesday, 14 May 2024
Seeking Alpha
Monday, 13 May 2024
Zacks Investment Research
Monday, 6 May 2024
GlobeNewsWire
Friday, 26 April 2024
GlobeNewsWire
Monday, 22 April 2024
Zacks Investment Research
Saturday, 6 April 2024
InvestorPlace
Monday, 25 March 2024
GlobeNewsWire
Wednesday, 21 February 2024
GlobeNewsWire
Thursday, 11 January 2024
Zacks Investment Research
Monday, 11 December 2023
Zacks Investment Research
Thursday, 23 November 2023
Zacks Investment Research
Tuesday, 21 November 2023
Zacks Investment Research
Wednesday, 25 October 2023
GlobeNewsWire
Friday, 13 October 2023
Zacks Investment Research
  • What's the price of OptimizeRx stock today?

    One share of OptimizeRx stock can currently be purchased for approximately $15.7.

  • When is OptimizeRx's next earnings date?

    Unfortunately, OptimizeRx's (OPRX) next earnings date is currently unknown.

  • Does OptimizeRx pay dividends?

    No, OptimizeRx does not pay dividends.

  • How much money does OptimizeRx make?

    OptimizeRx has a market capitalization of 77.64M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.53% to 71.52M US dollars.

  • What is OptimizeRx's stock symbol?

    OptimizeRx Corporation is traded on the NASDAQ under the ticker symbol "OPRX".

  • What is OptimizeRx's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of OptimizeRx?

    Shares of OptimizeRx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are OptimizeRx's key executives?

    OptimizeRx's management team includes the following people:

    • Mr. William J. Febbo Chief Executive Officer & Director(age: 56, pay: $626,590)
    • Mr. Stephen L. Silvestro Chief Commercial Officer(age: 47, pay: $485,560)
  • How many employees does OptimizeRx have?

    As Jul 2024, OptimizeRx employs 135 workers, which is 24% more then previous quarter.

  • When OptimizeRx went public?

    OptimizeRx Corporation is publicly traded company for more then 17 years since IPO on 28 Nov 2007.

  • What is OptimizeRx's official website?

    The official website for OptimizeRx is optimizerx.com.

  • Where are OptimizeRx's headquarters?

    OptimizeRx is headquartered at 400 Water Street, Rochester, MI.

  • How can i contact OptimizeRx?

    OptimizeRx's mailing address is 400 Water Street, Rochester, MI and company can be reached via phone at +248 6 516 568.

OptimizeRx company profile:

OptimizeRx Corporation

optimizerx.com
Exchange:

NASDAQ

Full time employees:

135

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

400 Water Street
Rochester, MI 48307

CIK: 0001448431
ISIN: US68401U2042
CUSIP: 68401U204